Multiomics tools for the diagnosis and treatment of rare neurological disease
Authors:
Open Access
- 13 March 2018
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 41 (3) , 425-434
Abstract
Conventional workup of rare neurological disease is frequently hampered by diagnostic delay or lack of diagnosis. While biomarkers have been established for many neurometabolic disorders, improved methods are required for diagnosis of previously unidentified or underreported causes of rare neurological disease. This would result in a higher diagnostic yield and increased patient numbers required for interventional studies. Recent studies using next‐generation sequencing and metabolomics have led to identification of novel disease‐causing genes and biomarkers. This combined approach can assist in overcoming challenges associated with analyzing and interpreting the large amount of data obtained from each technique. In particular, metabolomics can support the pathogenicity of sequence variants in genes encoding enzymes or transporters involved in metabolic pathways. Moreover, metabolomics can show the broader perturbation caused by inborn errors of metabolism and identify a metabolic fingerprint of metabolic disorders. As such, using “omics” has great potential to meet the current needs for improved diagnosis and elucidation of rare neurological disease.Keywords
Funding Information
- Universität Zürich (Rare disease initiative Zurich RadiZ)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_163302)
This publication has 69 references indexed in Scilit:
- Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiencyPLOS ONE, 2017
- Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe EncephalopathyThe American Journal of Human Genetics, 2017
- Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansionEpilepsia, 2015
- Proteomics beyond large-scale protein expression analysisCurrent Opinion in Biotechnology, 2015
- N8‐acetylspermidine as a potential plasma biomarker for Snyder‐Robinson syndrome identified by clinical metabolomicsJournal of Inherited Metabolic Disease, 2015
- Plasma proteomics to identify biomarkers – application to cardiovascular diseasesTranslational Proteomics, 2015
- Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathyJournal of Inherited Metabolic Disease, 2015
- UPLC‐QTOF/MS metabolic profiling unveils urinary changes in humans after a whole grain rye versus refined wheat bread interventionMolecular Nutrition & Food Research, 2013
- LC-MS METABOLOMICS FROM STUDY DESIGN TO DATA-ANALYSIS – USING A VERSATILE PATHOGEN AS A TEST CASEComputational and Structural Biotechnology Journal, 2013
- Accurate whole human genome sequencing using reversible terminator chemistryNature, 2008